MedPath

JONATHAN BERMAN

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Miltefosine Plus IL Pentamidine for Bolivian CL

Phase 2
Completed
Conditions
Leishmaniasis, Cutaneous
Interventions
First Posted Date
2018-02-26
Last Posted Date
2018-02-27
Lead Sponsor
Jonathan Berman
Target Recruit Count
50
Registration Number
NCT03445897

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.